TNXP

MKT CAP:$196M

Tonix Pharmaceuticals Holding Corp

Market Cap

$196M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$11.07-$5.48 (-33.11%)

Jun 5, 2026

52W High $61.5752W Low $11.07

Company Details

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in t...

CEO

—

IPO Date

May 10, 2012

Website

www.tonixpharma.com

Key Metrics TTM

Revenue

$18M

+74.8% YoY

Net Income

-$147M

EPS (Diluted)

Free Cash Flow

-$133M

Revenue / Share

$1.28

Gross Margin

52.6%

Operating Margin

-861.2%

Net Margin

-839.5%

FCF Margin

-755.6%

P/S

11.2x

P/E

Earnings Reports

Q1 2026

May 11, 2026

$7M+183.2%

FY 2025

Mar 12, 2026

$13M+29.8%

Q4 2025

Mar 12, 2026

$5M+108.8%

Q3 2025

Nov 10, 2025

$3M+16.6%

Q2 2025

Aug 11, 2025

$2M-9.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee